Our results showed that IL-6, IL-7, IL-10, and IL-17A levels were elevated in the plasma supernatants of NSCLC patients as compared to those in healthy controls but were significantly lower than those in the tumor tissue supernatant; this finding suggests an increased inflammatory response in the TME. This evidence concerns the gene IL7 and neoplasm.